Active	Status	Sponsor type	Region	Phase	Filter
5 Active 4 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Weidinger, Stephan
NCT05999799: A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis	Recruiting	2	199	Europe, Canada, Japan, US, RoW	GSK1070806, Placebo	GlaxoSmithKline	Dermatitis, Atopic	10/25	01/26
AbroSkib, NCT05140239: Effects of Abrocitinib Treatment on Skin Barrier Function	Active, not recruiting	N/A	20	Europe	No Intervention	Prof. Dr. Stephan Weidinger	Atopic Dermatitis	09/24	06/25
TREATgermany, NCT03057860: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis	Recruiting	N/A	2800	Europe	No study intervention	Technische Universität Dresden	Moderate-to-severe Atopic Dermatitis	12/26	12/26
NCT03358693: Molecular Signatures in Inflammatory Skin Disease	Recruiting	N/A	300	Europe	Ustekinumab, Infliximab, Secukinumab, Dupilumab, Brodalumab, Ixekizumab, Baricitinib, Abrocitinib, Upadacitinib, Tralokinumab	Prof. Dr. Stephan Weidinger	Atopic Dermatitis, Psoriasis	12/27	12/28
DiTrAP, NCT03361215: Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis	Recruiting	N/A	1000	Europe	Biosampling for molecular analysis	University Hospital Schleswig-Holstein	Atopic Dermatitis, Psoriasis, Healthy	03/28	12/30
Harder, Inken
No trials found